Written by Vivian Lei
Spoon Feed
The modified Valsalva maneuver is the most effective first-line vagal maneuver for stable supraventricular tachycardia, achieving higher conversion rates and reducing the need for intravenous antiarrhythmics without increasing adverse events.
Modify your Valsalva
This network meta-analysis evaluated the comparative effectiveness of four vagal maneuvers for hemodynamically stable supraventricular tachycardia (SVT): standard Valsalva maneuver (SVM), modified Valsalva maneuver (MVM), carotid sinus massage (CSM), and head-down deep breathing (HDDB). Nineteen randomized controlled trials (n = 2,545 adults) were included, using Bayesian network meta-analysis to rank efficacy and safety.
Across multiple clinically relevant outcomes, the MVM consistently outperformed SVM, CSM, and HDDB. The MVM more than doubled the likelihood of successful cardioversion on the first attempt compared with SVM and maintained superiority when assessed at the end of the trial period. Use of the MVM significantly reduced the need for rescue intravenous antiarrhythmic medications, such as adenosine, without an associated increase in adverse events. No meaningful differences in safety were detected among maneuvers, and patient age or sex did not modify effectiveness. Although HDDB ranked favorably for safety, conclusions were limited by sparse data from a single small trial.
How will this change my practice?
I nearly always attempt a modified Valsalva maneuver first in patients with stable SVT. These findings reinforce that the MVM should be taught, standardized, and routinely used as the default first-line vagal maneuver for the appropriate patient. Widespread adoption has the potential to improve first-attempt success, decrease medication exposure and ED resource utilization, and align bedside practice with the strongest available evidence, while also maintaining patient safety.
Another Spoonful
Just how might we modify the modified Valsalva? See this Lancet article, the REVERT RCT. Better yet, download the REVERT video from the Lancet demonstrating the “manoeuvre.”
Source
Pursuit of Optimal Vagal Maneuvers in Stable Supraventricular Tachycardia: A Network Meta-Analysis. West J Emerg Med. 2025 Nov 26;26(6):1667-1678. doi: 10.5811/westjem.47305. PMID: 41380061; PMCID: PMC12698150.
View JournalFeed Critical Appraisal
Critical Appraisal
Study Identification
Background
Study Question
Study Design & Conduct
Prospective / Retrospective: Not applicable
Multicenter: Yes
Unit of Allocation: Not applicable
Unit of Analysis: Patients
Randomization Method: Not applicable
Allocation Concealment: Not applicable
Blinding: Not applicable
Follow-up Duration: Immediate to short-term outcomes
Population
- Adults (≥ 18 years) with stable supraventricular tachycardia
- Diagnosed with SVT, including paroxysmal SVT, AVNRT, and AVRT
- Received one or more non-pharmacological vagal maneuvers
- Pediatric populations (< 18 years)
- Hemodynamic instability requiring immediate electrical cardioversion
- Structural heart disease
- Concomitant arrhythmias
Number Enrolled: 2,545
Number Analyzed: 2,545
Key Baseline Characteristics
Sex: 54.07% female
Disease Severity: Not reported
Care Setting Distribution: Emergency departments
Additional Baseline Characteristics
- Mean systolic blood pressure: 130.70 ± 23.17 mm Hg
- Mean diastolic blood pressure: 83.04 ± 15.55 mm Hg
- Mean initial pulse rate: 150.31 ± 48.87 bpm
- Type 2 diabetes mellitus: 21.47%
- Coronary artery disease: 25.61%
- Hypertension: 33.99%
Exposures / Interventions
Description: Modified Valsalva maneuver
Definition / Dose: Forced exhalation against resistance in a semi-recumbent position followed by supine repositioning with leg raise
Timing: Immediate application upon SVT diagnosis
Classification Method: Randomized controlled trials
Protocolized / Discretionary: Protocolized
Description: Standard Valsalva maneuver, carotid sinus massage, head-down deep breathing
Definition: Various techniques for vagal stimulation
Outcomes & Results
Primary Outcomes
Definition: Successful conversion of SVT to sinus rhythm after one application of the maneuver
Time Point: Immediate
Measurement Method: Electrocardiogram confirmation
Results: MVM vs SVM: RR 2.71, 95% Cr I, 2.26-3.31
Secondary Outcomes
Definition: Requirement for agents such as adenosine, verapamil, or sotalol after failed non-pharmacological maneuvers
Time Point: Immediate
Measurement Method: Clinical assessment
Results: MVM vs SVM: RR 0.64, 95% Cr I, 0.55-0.73
Definition: Occurrence of transient bradycardia, hypotension, syncope, or carotid hypersensitivity
Time Point: Immediate
Measurement Method: Clinical assessment
Results: No significant differences among maneuvers
Risk of Bias
Risk of Bias - AMSTAR 2
- Bias arising from the randomization process (Some concerns): Seven studies had insufficient details on randomization procedures.
- Bias due to deviations from intended interventions (Low): All studies were considered low risk for this domain.
- Bias due to missing outcome data (Some concerns): Thirteen studies lacked adequate information on participant selection.
- Bias in the measurement of outcomes (Some concerns): Outcome measurement bias was a concern in 11 studies due to subjective interpretation.
- Bias in the selection of the reported result (Low): All studies were considered low risk for selective outcome reporting.
Transparency
COI Statement Present: TRUE
